NCT05863052View on ClinicalTrials.gov

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

Active, not recruitingOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

January 31, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Immune Checkpoint InhibitorsMetastatic Solid TumorNonsmall Cell Lung CancerMelanomaRenal Cell CarcinomaGastrointestinal CancerSquamous Cell Carcinoma
Interventions
BIOLOGICAL

Immunotherapy

immunotherapy

Trial Locations (6)

57105

Avera Cancer Institute, Sioux Falls

57701

Monument Health Cancer Care Institute, Rapid City

73117

Stephenson Cancer Center, Oklahoma City

84112

Huntsman Cancer Institute at the University of Utah, Salt Lake City

85719

Arizona Cancer Center at the Unvieristy of Arizona, Tucson

87102

University of New Mexico Comprehensive Cancer Center, Albuquerque

All Listed Sponsors
lead

University of Oklahoma

OTHER